| Serum total and lipoprotein cholesterol levels and awareness, treatment, and control of hypercholesterolemia in China. | |
| | |
MedLine Citation:
|
PMID: 15238453 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Cardiovascular disease has become the leading cause of death in China. We examined the levels of serum total and lipoprotein cholesterol and status of awareness, treatment, and control of hypercholesterolemia in China. METHODS AND RESULTS: A cross-sectional survey in a nationally representative sample of 15,540 Chinese adults 35 to 74 years of age was conducted during 2000 to 2001. Serum cholesterol was measured by use of standard methods, and information on treatment of hyperlipidemia was obtained by use of a standard questionnaire. Age-standardized mean levels of total, HDL, and LDL cholesterol and triglycerides were 186.1, 51.7, 109.5, and 128.1 mg/dL, respectively. Of the Chinese population 35 to 74 years of age, 23.8% (112,500000 persons) had borderline high total cholesterol (200 to 239 mg/dL), and 9.0% (42,540000 persons) had high total cholesterol (> or =240 mg/dL). The population estimates for borderline high (130 to 159 mg/dL), high (160 to 189 mg/dL), and very high (> or =190 mg/dL) LDL cholesterol were 17.0% (80,122000 persons), 5.1% (24,329000 persons), and 2.7% (12,822000 persons), respectively. In addition, 19.2%, or 90 803 000 persons, had a low HDL cholesterol (<40 mg/dL). Among those who had a total cholesterol > or =200 mg/dL or who were on cholesterol-lowering medications, the proportion of men and women who were aware, treated, and controlled was only 8.8% and 7.5%, 3.5% and 3.4%, and 1.9% and 1.5%, respectively. CONCLUSIONS: The prevalence of hypercholesterolemia was relatively high and the percentage of adults with controlled blood cholesterol was low in China. Prevention and treatment of hypercholesterolemia should be an important component of a national strategy to reduce the substantial and increasing burden of cardiovascular disease in China. |
| | |
Authors:
|
Jiang He; Dongfeng Gu; Kristi Reynolds; Xigui Wu; Paul Muntner; Jiangong Zhao; Jing Chen; Donghai Liu; Jingping Mo; Paul K Whelton; |
Related Documents
:
|
19394473 - Almonds have a neutral effect on serum lipid profiles: a meta-analysis of randomized tr... 8213103 - Effect of norethisterone and levonorgestrel in low-dose multiphasic oral contraceptives... 228023 - Tolerance of mice to nitrous oxide. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2004-07-06 |
Journal Detail:
|
Title: Circulation Volume: 110 ISSN: 1524-4539 ISO Abbreviation: Circulation Publication Date: 2004 Jul |
Date Detail:
|
Created Date: 2004-07-27 Completed Date: 2005-01-25 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0147763 Medline TA: Circulation Country: United States |
Other Details:
|
Languages: eng Pagination: 405-11 Citation Subset: AIM; IM |
Affiliation:
|
Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, 1430 Tulane Ave SL18, New Orleans, LA 70112, USA. jhe@tulane.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Anticholesteremic Agents / therapeutic use China / epidemiology Cholesterol / blood* Cholesterol, HDL / blood* Cholesterol, LDL / blood* Complementary Therapies / utilization Cross-Sectional Studies Drug Utilization / statistics & numerical data Female Health Knowledge, Attitudes, Practice* Health Surveys Humans Hypercholesterolemia / blood, epidemiology*, psychology, therapy Life Style Male Middle Aged Prevalence Sampling Studies Triglycerides / blood |
| Chemical | |
Reg. No./Substance:
|
0/Anticholesteremic Agents; 0/Cholesterol, HDL; 0/Cholesterol, LDL; 0/Triglycerides; 57-88-5/Cholesterol |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Aggregated low-density lipoprotein uptake induces membrane tissue factor procoagulant activity and m...
Next Document: Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year fo...